- Home
- ALVR vs BIRD Comparison
ALVR vs BIRD Comparison
Compare ALVR & BIRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- BIRD
- Stock Information
- Founded
- ALVR 2013
- BIRD 2015
- Country
- ALVR United States
- BIRD United States
- Employees
- ALVR N/A
- BIRD N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- BIRD Apparel
- Sector
- ALVR Health Care
- BIRD Consumer Discretionary
- Exchange
- ALVR Nasdaq
- BIRD Nasdaq
- Market Cap
- ALVR 52.2M
- BIRD 55.3M
- IPO Year
- ALVR 2020
- BIRD 2021
- Fundamental
- Price
- ALVR $0.45
- BIRD $6.66
- Analyst Decision
- ALVR Sell
- BIRD Hold
- Analyst Count
- ALVR 1
- BIRD 3
- Target Price
- ALVR $0.50
- BIRD $18.00
- AVG Volume (30 Days)
- ALVR 325.1K
- BIRD 70.5K
- Earning Date
- ALVR 11-12-2024
- BIRD 11-06-2024
- Dividend Yield
- ALVR N/A
- BIRD N/A
- EPS Growth
- ALVR N/A
- BIRD N/A
- EPS
- ALVR N/A
- BIRD N/A
- Revenue
- ALVR N/A
- BIRD $205,895,000.00
- Revenue This Year
- ALVR N/A
- BIRD N/A
- Revenue Next Year
- ALVR N/A
- BIRD N/A
- P/E Ratio
- ALVR N/A
- BIRD N/A
- Revenue Growth
- ALVR N/A
- BIRD N/A
- 52 Week Low
- ALVR $0.40
- BIRD $6.54
- 52 Week High
- ALVR $1.05
- BIRD $25.60
- Technical
- Relative Strength Index (RSI)
- ALVR 41.21
- BIRD 32.46
- Support Level
- ALVR $0.42
- BIRD $6.54
- Resistance Level
- ALVR $0.48
- BIRD $7.43
- Average True Range (ATR)
- ALVR 0.04
- BIRD 0.49
- MACD
- ALVR 0.01
- BIRD -0.01
- Stochastic Oscillator
- ALVR 48.98
- BIRD 6.90
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About BIRD Allbirds Inc.
Allbirds Inc is a lifestyle brand that innovates with naturally derived materials to make footwear and apparel products in a better way, while treading lighter on the planet. Its primary source of revenue is from sales of shoes and apparel products. The majority of the revenue is derived from United States.